The Fraser Institute

The Fraser Institute

June 18, 2014 08:15 ET

Fraser Institute: How do Incremental Innovations in Pharmaceutical Industry Help Patients? New Study Coming Thursday, June 19

VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 18, 2014) - On Thursday, June 19, the Fraser Institute will release a new study examining incremental innovations by pharmaceutical companies.

The study, The Benefits of Incremental Innovation, spotlights the value of incremental innovations (relatively modest improvements to existing pharmaceutical drugs) to patients, treatment and research.

A news release with additional information will be issued via Marketwired on Thursday, June 19 at 6:30 a.m. (EST).

Follow the Fraser Institute on Twitter

Like us on Facebook

The Fraser Institute is an independent Canadian public policy research and educational organization with offices in Vancouver, Calgary, Toronto, and Montreal and ties to a global network of think-tanks in 87 countries. Its mission is to measure, study, and communicate the impact of competitive markets and government intervention on the welfare of individuals. To protect the Institute's independence, it does not accept grants from governments or contracts for research. Visit

Contact Information